US3198193A - Nasal inhaler - Google Patents

Nasal inhaler Download PDF

Info

Publication number
US3198193A
US3198193A US230085A US23008562A US3198193A US 3198193 A US3198193 A US 3198193A US 230085 A US230085 A US 230085A US 23008562 A US23008562 A US 23008562A US 3198193 A US3198193 A US 3198193A
Authority
US
United States
Prior art keywords
casing
projections
nasal
nasal inhaler
housing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US230085A
Inventor
Schwartzman Sam
Schwartzman Gilbert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US230085A priority Critical patent/US3198193A/en
Application granted granted Critical
Publication of US3198193A publication Critical patent/US3198193A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/08Inhaling devices inserted into the nose

Definitions

  • This invention relates to a device for relieving nasal congestion and more particularly to a refillable nasal inhaler.
  • Various types of nasal inhalers have been devised in the past in which medicaments, including Benzedrine, L-desoxyephedrine carbonate, ephedrine, menthol, camphor, eucalyptol, thymol, and other aromatics or the like have been packaged in a container provided with a projection for insertion into a nostril of the nose so that the vapors from the medication can be inhaled into the nasal passages to clear nasal and sinus congestion.
  • medicaments including Benzedrine, L-desoxyephedrine carbonate, ephedrine, menthol, camphor, eucalyptol, thymol, and other aromatics or the like have been packaged in a container provided with a projection for insertion into a nostril of the nose so that the vapors from the medication can be inhaled into the nasal passages to clear nasal and sinus congestion.
  • These prior nasal inhalers had been adapted for use in only one of the nostrils at a
  • the nasal inhaler is provided with a pair of ogive shaped projections which are adapted to be simultaneously inserted in both of the nostrils of the users nose whereby the medicament vapors can be inhaled into both nostrils simultaneously to clear the nasal and sinus passages.
  • the projections are ogive shaped rather than being of the shapes heretofore used which would normally expand the nostrils beyond the possibility of comfortably inserting two separate projections into both of the nostrils simultaneously.
  • the ogive shape permits a good seal of the flesh surrounding each nostril opening to be had while permitting comfortable insertion of both projections into both nostrils. Further, by the arrangement alforded, it is possible to insert only one projection into a single nostril as may be desired.
  • An object of the present invention resides in the provision of a nasal inhaler having means for permitting the refilling thereof in a convenient manner and which is adapted to be molded out of suitable synthetic plastic materials and which can be made of metal or the like whereby a highly attractive and extraordinarily effective medication dispensing device can be attained.
  • the nasal inhaler comprises a housing in which a casing is removably seated.
  • the casing has side walls and has a contoured concave top wall extending beyond the housing and provided with a pair of spaced ogive shaped projections.
  • the top wall is further provided with a groove between the projections for accommodating portions ofthe nose.
  • a wadding of absorbent material is disposed in the casing and extends into the projection, onto which medicament may be poured so that the aromatic vapors thereof may be inhaled through projections in the perforations into the nostrils of the users nose.
  • Still further objects and features of this invention reside in the provision of a nasal inhaler which is simple in construction, capable of being manufactured by mass pro- 3,198,193 Patented lAng. 3, 1965 ACC duction methods, and which is relatively inexpensive to produce thereby permitting wide use and distribution.
  • FlG. 1 is an exploded perspective view of an embodiment of the nasal inhaler
  • FIG. 2 is an exploded elevational view of the nasal inhaler shown with the casing mounted in the housing and with the top removed from the casing, with parts of the nasal inhaler being in sections showing details of construction;
  • FIG. 3 is a Vertical sectional View of the nasal inhaler illustrating the manner of use thereof with a portion of the wadding being broken away to show details of construction of the invention
  • FIG. 4 is a horizontal sectional view taken along the plane of line 4 4 in FIG. 3;
  • FIG. 5 is a vertical sectional view taken along the plane of line 5 5 in FIG. 3 illustrating the invention with the top added to show the relative relation of parts and the manner of sealing olf the perforations in the projections by the top;
  • FIG. 6 is a bottom plan View of the top taken along the plane of line 6-6 in FIG. l.
  • reference numeral 10 generally designates the nasal inhaler comprising an illustrative embodiment of the present invention.
  • the nasal inhaler 10 includes four main parts, a housing 12, a casing 14, a top 16, and a wadding 18 of cotton or other suitable absorbent material.
  • the housing 12 is in the form of a base container having a bottom 20 and peripheral walls 22 which are rectangular in shape and which are provided with upper' portions 24 of reduced thickness forming a shoulder Z6 so that when the top 16 is positioned ⁇ over the casing 14, the lower edge 28 of the top will engage the shoulder 26.
  • the top 16 has an upper wall 30 and rectangular side walls 32.
  • the casing 14 has a pair of spaced end walls 34 and 36 of rectangular shape which are provided with notches 38, 4G therein and which have ribs 42, 44 thereon, for frictional abutting engagement with the inner surfaces of the peripheral wall 22.
  • the side Walls 48 and 5t) of the casing 14 are likewise provided with projections 52 and 54 for engaging the inner surfaces of the peripheral wall 22; for spacing the casing 14 for the housing 12, and for resiliently mounting the casing 14 within the housing 12 with air spaces as indicated at A, FIG. 4, to permit the passage of air between the casing 14 and the housing 12 and through the notches 38, 40 into the interior of the casing 36.
  • the top wall 56 of the casing is contoured concavely as can be seen best in FIGS. l, 2 and 3 and is further provided with a groove 58 centrally disposed between two spaced ogive-shaped projections 60 and 62 which rise from the top wall 56 and which are hollow and communicate with the interior of the casing 14.
  • ogiveeshaped projections are provided with perforations or apertures 64, 66 in their uppermost ends and are spaced a, sa from each other on either side of the groove SS so as to readily it into the nostrils of the nose N, see FiG. 3, of a patient or user.
  • These ogive-shaped projections are so constructed that they do not distort the nostrils or nasal passages to the extent tha-t conventional nasal inhalers push aside the various portions of the nose to il the nostril. This is because when two projections 60 and 62 are used in the manner shown in FIG.
  • the nostrils are entirely filled up so that good suction is attained and the patient inhaling and using the nasal inhaler will receive the entire benefit of the medication which is disposed on and saturates a cotton wadding 70 which llsthe casing 14 and which extends into the projections 60 and 62.
  • conventionally-shaped projections instead of ogive-shaped projections were to be used, the nostrils would be distorted, and the user rendered most uncomfortable.
  • the ogive-shapcd projections fit conveniently and comfortably into the nostrils of the nose with the dividing bridge between the nostrils of the nose seating in the groove 58 in a comfortable manner.
  • the nasal inhaler may be used for inhalation through a single nostril by merely positioning lonekof the projections into the nostril and closing the other nostril, by either using the fingers of the hand holding the nasal inhaler or the lingers of the other hand,
  • the top 16 has a pair of truncated conically-shaped projections or detents 80 and 82 which extend downwardly from the inner surface of the top 16 and which are adapted to engage within the perforations 64 and 66 to seal these perforations against passage of aromatic vapors when the top is in the closed position as shown in FIG. 5.
  • the nasal inhaler is preferably used as shown in PIG. 3.
  • the user inhales a medication consisting of Various types of aromatic or volatile medicaments, such as ephedrine, menthol camphor, eucalyptol, thymol, benzedrine, or the like or any combination thereof, as conventionally employed in nasal inhalers.
  • This medication may be carried ina suitable mineral oil base or the like and because of the construction of this nasal inhaler, the medication may be replaced by merely pouring additional medication onto the cotton wadding after the casing 14 has been removed from the housing 12. When the wadding has been so saturated with the medication, the wadding may be entirely removed and new wadding added in a convenient manner whereby additional medication may be employed. This has not been possible in previous nasal applicators since the use ⁇ of a mineral oil base medicament for relling the Vaporizer would eventually render vthe vaporizer unuseable'and unreilable.
  • a nasal inhaler comprising a housing having a bottom and peripheral side and end walls, a casing removably seated in said housing, said casing having side and end walls sitting on side bottom said endwalls being provided with relatively small rectagular notches at their lowermost portions, said casing having a contoured concave top wall extending beyond said peripheral walls, said casing side walls having projections thereon for resiliently frictionally engaging said side walls of said housing, said end walls having ribs thereon resiliently frictionally engaging said end walls of said housing, said projection means and said ribs defining relatively small air spaces between 'said casing and said side and end walls of said housing, side air spaces connecting with said notches said concave top wall having a pair of spaced ogive-shaped projections extending therefrom, said concave top wall having a groove therein between said projections, said groove extending below the lowest part of said top wall, said projections having perforations therethrough, through which air containing medicament vapors can be drawn, a wadding of

Description

Aug- 3 1965 s. scHwARTzMAN ETAL 3,198,193
NASAL INHALER Filed 001;. l2
United States Patent O 3,198,193 NASAL INHALER Sam Schwartzman, Dellorest Corners, Brewster, NY., and Gilbert Schwartzman, 20 Wilmot Circle, Scarsdale,
Filed oct. 12,-1962,se1. No. zsaoss 1 claim. (ci. 12s-19s) This invention relates to a device for relieving nasal congestion and more particularly to a refillable nasal inhaler.
Various types of nasal inhalers have been devised in the past in which medicaments, including Benzedrine, L-desoxyephedrine carbonate, ephedrine, menthol, camphor, eucalyptol, thymol, and other aromatics or the like have been packaged in a container provided with a projection for insertion into a nostril of the nose so that the vapors from the medication can be inhaled into the nasal passages to clear nasal and sinus congestion. These prior nasal inhalers had been adapted for use in only one of the nostrils at a time by requiring that the other nostril be closed manually so that better suction of the medicament vapors can be attained.
In accordance with the concept of the present invention, the nasal inhaler is provided with a pair of ogive shaped projections which are adapted to be simultaneously inserted in both of the nostrils of the users nose whereby the medicament vapors can be inhaled into both nostrils simultaneously to clear the nasal and sinus passages. This is brought about by the fact that the projections are ogive shaped rather than being of the shapes heretofore used which would normally expand the nostrils beyond the possibility of comfortably inserting two separate projections into both of the nostrils simultaneously. The ogive shape permits a good seal of the flesh surrounding each nostril opening to be had while permitting comfortable insertion of both projections into both nostrils. Further, by the arrangement alforded, it is possible to insert only one projection into a single nostril as may be desired.
An object of the present invention resides in the provision of a nasal inhaler having means for permitting the refilling thereof in a convenient manner and which is adapted to be molded out of suitable synthetic plastic materials and which can be made of metal or the like whereby a highly attractive and extraordinarily effective medication dispensing device can be attained.
In accordance with an illustrative embodiment of the present invention, the nasal inhaler comprises a housing in which a casing is removably seated. The casing has side walls and has a contoured concave top wall extending beyond the housing and provided with a pair of spaced ogive shaped projections. The top wall is further provided with a groove between the projections for accommodating portions ofthe nose. A wadding of absorbent material is disposed in the casing and extends into the projection, onto which medicament may be poured so that the aromatic vapors thereof may be inhaled through projections in the perforations into the nostrils of the users nose.
Still further objects and features of this invention reside in the provision of a nasal inhaler which is simple in construction, capable of being manufactured by mass pro- 3,198,193 Patented lAng. 3, 1965 ACC duction methods, and which is relatively inexpensive to produce thereby permitting wide use and distribution.
These, together with the various ancillary objects and features of the invention which will become apparent as the following description proceeds, are attained by this nasal inhaler, a preferred embodiment of which has been illustrated in the accompanying drawings, by `way of example only, wherein:
FlG. 1 is an exploded perspective view of an embodiment of the nasal inhaler;
FIG. 2 is an exploded elevational view of the nasal inhaler shown with the casing mounted in the housing and with the top removed from the casing, with parts of the nasal inhaler being in sections showing details of construction;
FIG. 3 is a Vertical sectional View of the nasal inhaler illustrating the manner of use thereof with a portion of the wadding being broken away to show details of construction of the invention;
FIG. 4 is a horizontal sectional view taken along the plane of line 4 4 in FIG. 3;
FIG. 5 is a vertical sectional view taken along the plane of line 5 5 in FIG. 3 illustrating the invention with the top added to show the relative relation of parts and the manner of sealing olf the perforations in the projections by the top; and
FIG. 6 is a bottom plan View of the top taken along the plane of line 6-6 in FIG. l.
With continuing reference to the accompanying drawings Wherein like reference numerals designate similar parts throughout the various views, reference numeral 10 generally designates the nasal inhaler comprising an illustrative embodiment of the present invention. The nasal inhaler 10 includes four main parts, a housing 12, a casing 14, a top 16, and a wadding 18 of cotton or other suitable absorbent material.
The housing 12 is in the form of a base container having a bottom 20 and peripheral walls 22 which are rectangular in shape and which are provided with upper' portions 24 of reduced thickness forming a shoulder Z6 so that when the top 16 is positioned `over the casing 14, the lower edge 28 of the top will engage the shoulder 26. The top 16 has an upper wall 30 and rectangular side walls 32.
The casing 14 has a pair of spaced end walls 34 and 36 of rectangular shape which are provided with notches 38, 4G therein and which have ribs 42, 44 thereon, for frictional abutting engagement with the inner surfaces of the peripheral wall 22. The side Walls 48 and 5t) of the casing 14 are likewise provided with projections 52 and 54 for engaging the inner surfaces of the peripheral wall 22; for spacing the casing 14 for the housing 12, and for resiliently mounting the casing 14 within the housing 12 with air spaces as indicated at A, FIG. 4, to permit the passage of air between the casing 14 and the housing 12 and through the notches 38, 40 into the interior of the casing 36. The top wall 56 of the casing is contoured concavely as can be seen best in FIGS. l, 2 and 3 and is further provided with a groove 58 centrally disposed between two spaced ogive- shaped projections 60 and 62 which rise from the top wall 56 and which are hollow and communicate with the interior of the casing 14. The
ogiveeshaped projections are provided with perforations or apertures 64, 66 in their uppermost ends and are spaced a, sa from each other on either side of the groove SS so as to readily it into the nostrils of the nose N, see FiG. 3, of a patient or user. These ogive-shaped projections are so constructed that they do not distort the nostrils or nasal passages to the extent tha-t conventional nasal inhalers push aside the various portions of the nose to il the nostril. This is because when two projections 60 and 62 are used in the manner shown in FIG. 3, the nostrils are entirely filled up so that good suction is attained and the patient inhaling and using the nasal inhaler will receive the entire benefit of the medication which is disposed on and saturates a cotton wadding 70 which llsthe casing 14 and which extends into the projections 60 and 62. if, for example, conventionally-shaped projections, instead of ogive-shaped projections were to be used, the nostrils would be distorted, and the user rendered most uncomfortable. However, the ogive-shapcd projections fit conveniently and comfortably into the nostrils of the nose with the dividing bridge between the nostrils of the nose seating in the groove 58 in a comfortable manner.
On the other hand, the nasal inhaler may be used for inhalation through a single nostril by merely positioning lonekof the projections into the nostril and closing the other nostril, by either using the fingers of the hand holding the nasal inhaler or the lingers of the other hand,
The top 16 has a pair of truncated conically-shaped projections or detents 80 and 82 which extend downwardly from the inner surface of the top 16 and which are adapted to engage within the perforations 64 and 66 to seal these perforations against passage of aromatic vapors when the top is in the closed position as shown in FIG. 5.
The nasal inhaler is preferably used as shown in PIG. 3. The user inhales a medication consisting of Various types of aromatic or volatile medicaments, such as ephedrine, menthol camphor, eucalyptol, thymol, benzedrine, or the like or any combination thereof, as conventionally employed in nasal inhalers. This medication may be carried ina suitable mineral oil base or the like and because of the construction of this nasal inhaler, the medication may be replaced by merely pouring additional medication onto the cotton wadding after the casing 14 has been removed from the housing 12. When the wadding has been so saturated with the medication, the wadding may be entirely removed and new wadding added in a convenient manner whereby additional medication may be employed. This has not been possible in previous nasal applicators since the use `of a mineral oil base medicament for relling the Vaporizer would eventually render vthe vaporizer unuseable'and unreilable.
A latitude of modification, change and substitution is intended in the foregoing disclosure, and in some instances some features of the invention will be employed without a corresponding use of other features. Accordingly, it is appropriate that the appended claim be construed broadly and in a manner consistent with the spirit and scope of the invention herein.
We claim:
A nasal inhaler comprising a housing having a bottom and peripheral side and end walls, a casing removably seated in said housing, said casing having side and end walls sitting on side bottom said endwalls being provided with relatively small rectagular notches at their lowermost portions, said casing having a contoured concave top wall extending beyond said peripheral walls, said casing side walls having projections thereon for resiliently frictionally engaging said side walls of said housing, said end walls having ribs thereon resiliently frictionally engaging said end walls of said housing, said projection means and said ribs defining relatively small air spaces between 'said casing and said side and end walls of said housing, side air spaces connecting with said notches said concave top wall having a pair of spaced ogive-shaped projections extending therefrom, said concave top wall having a groove therein between said projections, said groove extending below the lowest part of said top wall, said projections having perforations therethrough, through which air containing medicament vapors can be drawn, a wadding of an absorbent material in said casing and extending into said projections and against said bottom, said side and end wall air spaces serving to permit entry of replenishing air through said notches and hence through said wadding, and a top on said casing, said top having a pair of tapered detents engageable in said perforations closing said perforations.
References Cited by the Examiner UNlTED STATES PATENTS 382,113 5/88 Sharp 128-200 1,340,662 5/20 Lobl 128-198 1,540,274 6/25 Moore 12S-198 2,310,681 2/43 Derham et al 128--200 2,412,269 12/46 Hor 128--206 2,460,955 2/49 Todd 128-200 2,603,216 7/52 Taplin et al. 12S-206 2,641,254 6/56 Brown 12S-206 2,745,402 5/56 Dufresne 12S-200 FOREIGN PATENTS 24,365 1895 Great Britain.
0 RICHARD A. GAUDET, Primary Examiner.
JORDAN FRANKLIN, Examiner.
US230085A 1962-10-12 1962-10-12 Nasal inhaler Expired - Lifetime US3198193A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US230085A US3198193A (en) 1962-10-12 1962-10-12 Nasal inhaler

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US230085A US3198193A (en) 1962-10-12 1962-10-12 Nasal inhaler

Publications (1)

Publication Number Publication Date
US3198193A true US3198193A (en) 1965-08-03

Family

ID=22863899

Family Applications (1)

Application Number Title Priority Date Filing Date
US230085A Expired - Lifetime US3198193A (en) 1962-10-12 1962-10-12 Nasal inhaler

Country Status (1)

Country Link
US (1) US3198193A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3724459A (en) * 1971-06-07 1973-04-03 P Congro Dual inhaler
US3788316A (en) * 1971-04-07 1974-01-29 M Mora Pocket nasal inhaler
US6684879B1 (en) * 1998-12-17 2004-02-03 Battelle Memorial Institute Inhaler
US20050205685A1 (en) * 2002-07-17 2005-09-22 Jones Stuart M R Dispenser
US20050229815A1 (en) * 2002-06-28 2005-10-20 Reckitt Benckiser (Uk) Limited Candle composition and candles made therefrom
WO2008122791A2 (en) * 2007-04-05 2008-10-16 Optinose As Nasal delivery
US20100024813A1 (en) * 2001-02-27 2010-02-04 Donald Spector Aromatherapy Method
USD828543S1 (en) * 2017-08-01 2018-09-11 Khanquer Pharma, Inc. Dual nostril nasal spray device

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US382113A (en) * 1888-05-01 Inhaler
GB189524365A (en) * 1895-12-19 1896-10-10 Anglo Swedish Trading Ass Ltd An Improved Inhaler.
US1340662A (en) * 1917-06-21 1920-05-18 Lobl Frederick Inhaler
US1540274A (en) * 1924-03-28 1925-06-02 William J Moore Nasal inhaler
US2310681A (en) * 1942-03-04 1943-02-09 Victor Metal Products Corp Inhaler
US2412269A (en) * 1944-08-11 1946-12-10 Hor Quan Nose pump
US2460955A (en) * 1946-05-17 1949-02-08 Paul H Todd Inhaler
US2603216A (en) * 1952-07-15 Powder inhaler
US2641254A (en) * 1948-10-18 1953-06-09 Frederick M Turnbull Applicator
US2745402A (en) * 1953-06-15 1956-05-15 Oliver J Dufresne Inhaler

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US382113A (en) * 1888-05-01 Inhaler
US2603216A (en) * 1952-07-15 Powder inhaler
GB189524365A (en) * 1895-12-19 1896-10-10 Anglo Swedish Trading Ass Ltd An Improved Inhaler.
US1340662A (en) * 1917-06-21 1920-05-18 Lobl Frederick Inhaler
US1540274A (en) * 1924-03-28 1925-06-02 William J Moore Nasal inhaler
US2310681A (en) * 1942-03-04 1943-02-09 Victor Metal Products Corp Inhaler
US2412269A (en) * 1944-08-11 1946-12-10 Hor Quan Nose pump
US2460955A (en) * 1946-05-17 1949-02-08 Paul H Todd Inhaler
US2641254A (en) * 1948-10-18 1953-06-09 Frederick M Turnbull Applicator
US2745402A (en) * 1953-06-15 1956-05-15 Oliver J Dufresne Inhaler

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3788316A (en) * 1971-04-07 1974-01-29 M Mora Pocket nasal inhaler
US3724459A (en) * 1971-06-07 1973-04-03 P Congro Dual inhaler
US6684879B1 (en) * 1998-12-17 2004-02-03 Battelle Memorial Institute Inhaler
US20040079360A1 (en) * 1998-12-17 2004-04-29 Coffee Ronald Alan Nasal inhaler
US20100024813A1 (en) * 2001-02-27 2010-02-04 Donald Spector Aromatherapy Method
US20050229815A1 (en) * 2002-06-28 2005-10-20 Reckitt Benckiser (Uk) Limited Candle composition and candles made therefrom
US7018432B2 (en) 2002-06-28 2006-03-28 Reckitt Benckiser (Uk) Limited Candle composition and candles made therefrom
US20050205685A1 (en) * 2002-07-17 2005-09-22 Jones Stuart M R Dispenser
WO2008122791A2 (en) * 2007-04-05 2008-10-16 Optinose As Nasal delivery
WO2008122791A3 (en) * 2007-04-05 2009-06-25 Optinose As Nasal delivery
US20100282246A1 (en) * 2007-04-05 2010-11-11 Optinose As Nasal delivery
US8978647B2 (en) 2007-04-05 2015-03-17 Optinose, AS Nasal delivery
US10076615B2 (en) 2007-04-05 2018-09-18 Optinose As Nasal delivery
EP3777939A3 (en) * 2007-04-05 2021-05-12 Optinose AS Nasal delivery
USD828543S1 (en) * 2017-08-01 2018-09-11 Khanquer Pharma, Inc. Dual nostril nasal spray device

Similar Documents

Publication Publication Date Title
US3565071A (en) Self-regulating therapeutic inhaler
US4291688A (en) Inhalation device
US2123353A (en) Inhaler
US2587215A (en) Inhalator
US4852561A (en) Inhalation device
JP3014405B2 (en) Auxiliary device for aerosol inhaler
US7032593B2 (en) Inhalation device and method
JP5919277B2 (en) Holding chamber with valve including valve holding system
JPH06205832A (en) Valve mechanism and aerosol inhaler device with it
US3198193A (en) Nasal inhaler
JP2525473B2 (en) Powdered drug dispensing container
US3255750A (en) Inhaler
US3027897A (en) Nasal inhaler
ZA200500235B (en) Dispenser
US2305173A (en) Headrest
US3393677A (en) Inhaling mask
EP0014814A1 (en) Inhalation device and sounding device for it
US1950926A (en) Nasal inhaler
US6397837B1 (en) Inhaler assistive device
US1985001A (en) Inhaler
RU2533949C1 (en) Volatile drug inhaler
US20210187212A1 (en) Inhaler and method
US1599111A (en) Inhaler
EP0075548A2 (en) Medical aerosol dispensing device
US2641255A (en) Inhaler